Beta Bionics Sees FY2026 Sales $130.000M-$135.000M vs $132.717M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Beta Bionics (NASDAQ:BBNX) sees FY2026 sales of $130.000 million-$135.000 million vs $132.717 million analyst estimate.
Beta Bionics (NASDAQ:BBNX) sees FY2026 sales of $130.000 million-$135.000 million vs $132.717 million analyst estimate.